TPG buyout nears close after Q1 miss. With shares near a $76 cash offer, the upside for HOLX investors looks dim.

Hologic’s fair value estimate has been nudged from US$76.92 to US$76.60, a small shift that keeps it closely aligned with the proposed US$79 all cash takeout price. This fine tuning mainly reflects ...

With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...

The latest announcement is out from Hologic ( (HOLX) ).

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...

WNBA star Erica Wheeler, whose mother died of the disease, stars in "Ultimate Defense," a campaign emphasizing the importance ...

Medical technology company Hologic (NASDAQ:HOLX) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 2.5% year on year to $1.05 billion. Its non-GAAP profit of $1.04 per share was 5.4 ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...

Though the vast majority of women are aware of the importance of early screening for various cancers and other life-threatening health conditions, a new survey estimates that nearly half of those in ...

Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...